Skip to content
Screener

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.27-0.9%
AbbVie logo
AbbVieABBV
$2.03+290%
IAR
Integra LifeSciencesIART
$0.06+101%
Artivion logo
ArtivionAORT
-$0.28-1,033%
Globus Medical logo
Globus MedicalGMED
$1.10-26.2%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$0.39-8.3%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.28B+134%
Enterprise value$2.47B+115%
P/S9.3×+3.8×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Numerator:
Net loss$(11,748)$(16,593)$(25,130)$(37,303)
Denominator:
Weighted average common shares used for basic and diluted earnings per share30,121,68528,913,81130,037,82628,882,108
Net loss per share:
Basic and diluted$(0.39)$(0.57)$(0.84)$(1.29)

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's EPS (diluted)?
Establishment Labs (ESTA) reported EPS (diluted) of -$0.39 in Q2 2026.
How has Establishment Labs's EPS (diluted) changed year-over-year?
Establishment Labs's EPS (diluted) increased by 31.6% year-over-year, from -$0.57 to -$0.39.
What is the long-term trend for Establishment Labs's EPS (diluted)?
Over 4 years (2021 to 2025), Establishment Labs's EPS (diluted) has grown at a 0.3% compound annual growth rate (CAGR), from -$1.71 to -$1.73.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Establishment Labs's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude